Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromosomes, Human, Y | 14 | 2020 | 163 | 2.720 |
Why?
|
Lebanon | 40 | 2024 | 245 | 2.650 |
Why?
|
Genetics, Population | 23 | 2024 | 942 | 2.280 |
Why?
|
Haplotypes | 25 | 2024 | 2724 | 2.230 |
Why?
|
Gene Flow | 8 | 2024 | 79 | 1.810 |
Why?
|
Coronary Artery Disease | 20 | 2024 | 6567 | 1.460 |
Why?
|
DNA, Mitochondrial | 10 | 2018 | 871 | 1.430 |
Why?
|
Polymorphism, Single Nucleotide | 33 | 2024 | 16028 | 1.400 |
Why?
|
Coronary Stenosis | 4 | 2023 | 802 | 1.320 |
Why?
|
Emigration and Immigration | 7 | 2018 | 406 | 1.240 |
Why?
|
Cholesterol, HDL | 7 | 2024 | 1820 | 1.120 |
Why?
|
Genetic Predisposition to Disease | 20 | 2024 | 18048 | 1.060 |
Why?
|
Apolipoprotein C-I | 1 | 2024 | 14 | 0.970 |
Why?
|
Population | 3 | 2020 | 141 | 0.930 |
Why?
|
Diabetes Mellitus, Type 2 | 12 | 2024 | 12241 | 0.830 |
Why?
|
Globins | 4 | 2005 | 405 | 0.830 |
Why?
|
Refugees | 2 | 2023 | 612 | 0.790 |
Why?
|
Plasma | 3 | 2020 | 585 | 0.770 |
Why?
|
Genome-Wide Association Study | 13 | 2024 | 12778 | 0.740 |
Why?
|
Genetic Variation | 19 | 2019 | 6606 | 0.730 |
Why?
|
Genome, Mitochondrial | 2 | 2018 | 68 | 0.730 |
Why?
|
History, Ancient | 11 | 2019 | 213 | 0.710 |
Why?
|
Transcription Factor 7-Like 2 Protein | 2 | 2023 | 152 | 0.680 |
Why?
|
Urine | 1 | 2020 | 363 | 0.640 |
Why?
|
Sphingomyelins | 1 | 2019 | 105 | 0.620 |
Why?
|
beta-Thalassemia | 4 | 2005 | 236 | 0.610 |
Why?
|
Diabetes Mellitus, Type 1 | 10 | 2013 | 3440 | 0.590 |
Why?
|
Population Dynamics | 5 | 2018 | 314 | 0.520 |
Why?
|
Protein Kinase C-alpha | 1 | 2016 | 113 | 0.520 |
Why?
|
Women | 1 | 2018 | 226 | 0.520 |
Why?
|
Consanguinity | 6 | 2013 | 460 | 0.500 |
Why?
|
Phylogeny | 9 | 2018 | 2843 | 0.480 |
Why?
|
Metabolomics | 6 | 2020 | 1674 | 0.480 |
Why?
|
Alleles | 9 | 2024 | 6892 | 0.470 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2014 | 111 | 0.460 |
Why?
|
Demography | 1 | 2018 | 1642 | 0.420 |
Why?
|
Genome, Human | 11 | 2019 | 4450 | 0.400 |
Why?
|
Phylogeography | 6 | 2019 | 72 | 0.400 |
Why?
|
Respiratory Sounds | 1 | 2016 | 702 | 0.390 |
Why?
|
Syria | 4 | 2023 | 86 | 0.390 |
Why?
|
Genotype | 16 | 2024 | 13042 | 0.360 |
Why?
|
Aortic Valve | 1 | 2020 | 1969 | 0.360 |
Why?
|
Peptidyl-Dipeptidase A | 2 | 2010 | 326 | 0.350 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2016 | 4357 | 0.350 |
Why?
|
Evolution, Molecular | 6 | 2020 | 1893 | 0.350 |
Why?
|
Humans | 121 | 2024 | 768393 | 0.340 |
Why?
|
Polymorphism, Genetic | 7 | 2021 | 4250 | 0.330 |
Why?
|
Cholesterol | 1 | 2019 | 2912 | 0.330 |
Why?
|
Risk Factors | 31 | 2024 | 74962 | 0.330 |
Why?
|
Lipoprotein(a) | 2 | 2023 | 490 | 0.320 |
Why?
|
Acculturation | 1 | 2010 | 179 | 0.320 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 2020 | 352 | 0.320 |
Why?
|
Gene Frequency | 11 | 2017 | 3617 | 0.320 |
Why?
|
Male | 69 | 2024 | 364902 | 0.320 |
Why?
|
Ectodysplasins | 1 | 2008 | 12 | 0.320 |
Why?
|
Middle East | 7 | 2016 | 233 | 0.310 |
Why?
|
Drug Resistance, Viral | 1 | 2014 | 869 | 0.310 |
Why?
|
RNA, Viral | 4 | 2014 | 2866 | 0.310 |
Why?
|
Anemia, Sickle Cell | 2 | 2010 | 1065 | 0.310 |
Why?
|
Communicable Diseases | 1 | 2016 | 873 | 0.300 |
Why?
|
Aortic Valve Stenosis | 1 | 2020 | 2034 | 0.300 |
Why?
|
Polymerase Chain Reaction | 7 | 2007 | 6085 | 0.300 |
Why?
|
Constriction, Pathologic | 4 | 2023 | 1104 | 0.290 |
Why?
|
Principal Component Analysis | 5 | 2024 | 948 | 0.290 |
Why?
|
Ectodermal Dysplasia | 1 | 2008 | 107 | 0.290 |
Why?
|
Hypertension | 4 | 2024 | 8615 | 0.280 |
Why?
|
Genetic Association Studies | 3 | 2017 | 2742 | 0.280 |
Why?
|
Archaeology | 2 | 2018 | 37 | 0.270 |
Why?
|
Pedigree | 4 | 2020 | 4544 | 0.270 |
Why?
|
Genetic Loci | 3 | 2023 | 2630 | 0.260 |
Why?
|
Case-Control Studies | 9 | 2024 | 22296 | 0.260 |
Why?
|
Greece | 2 | 2024 | 340 | 0.250 |
Why?
|
Codon | 2 | 2008 | 599 | 0.250 |
Why?
|
Microsatellite Repeats | 5 | 2020 | 784 | 0.250 |
Why?
|
Arabia | 1 | 2024 | 6 | 0.250 |
Why?
|
Yemen | 1 | 2024 | 10 | 0.250 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2023 | 4641 | 0.250 |
Why?
|
Middle Aged | 35 | 2024 | 223491 | 0.250 |
Why?
|
Proteobacteria | 1 | 2005 | 47 | 0.240 |
Why?
|
Female | 54 | 2024 | 397089 | 0.240 |
Why?
|
Turkey | 2 | 2024 | 256 | 0.240 |
Why?
|
Gene Pool | 4 | 2019 | 36 | 0.230 |
Why?
|
Phenotype | 11 | 2021 | 16721 | 0.230 |
Why?
|
Microfilament Proteins | 2 | 2024 | 1135 | 0.230 |
Why?
|
Water Microbiology | 1 | 2005 | 117 | 0.230 |
Why?
|
Anti-Retroviral Agents | 1 | 2014 | 1794 | 0.230 |
Why?
|
Qb-SNARE Proteins | 1 | 2023 | 34 | 0.230 |
Why?
|
Genetic Testing | 4 | 2006 | 3587 | 0.220 |
Why?
|
DNA, Ribosomal | 1 | 2005 | 301 | 0.220 |
Why?
|
Water Supply | 1 | 2005 | 204 | 0.220 |
Why?
|
Mutation, Missense | 2 | 2014 | 2593 | 0.220 |
Why?
|
Linkage Disequilibrium | 3 | 2024 | 1998 | 0.220 |
Why?
|
Fetal Hemoglobin | 2 | 2003 | 346 | 0.220 |
Why?
|
Chromosome Disorders | 1 | 2006 | 499 | 0.210 |
Why?
|
Seafood | 1 | 2006 | 395 | 0.210 |
Why?
|
Coronary Angiography | 4 | 2023 | 4537 | 0.210 |
Why?
|
Africa, Northern | 6 | 2019 | 86 | 0.200 |
Why?
|
Thalassemia | 1 | 2003 | 267 | 0.200 |
Why?
|
Hepatocyte Nuclear Factor 6 | 1 | 2021 | 10 | 0.200 |
Why?
|
Odds Ratio | 6 | 2021 | 9682 | 0.190 |
Why?
|
China | 6 | 2022 | 2395 | 0.190 |
Why?
|
Adult | 39 | 2024 | 223640 | 0.190 |
Why?
|
Antigens, Differentiation | 1 | 2004 | 921 | 0.190 |
Why?
|
Genetic Heterogeneity | 1 | 2005 | 737 | 0.190 |
Why?
|
Geography | 5 | 2015 | 654 | 0.180 |
Why?
|
Mediterranean Region | 2 | 2018 | 47 | 0.180 |
Why?
|
Aged | 26 | 2024 | 171562 | 0.180 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2021 | 118 | 0.180 |
Why?
|
Mutation | 9 | 2013 | 30228 | 0.180 |
Why?
|
Fruit | 1 | 2006 | 1164 | 0.180 |
Why?
|
Nicotine | 1 | 2005 | 680 | 0.180 |
Why?
|
Spain | 2 | 2019 | 492 | 0.180 |
Why?
|
Africa | 5 | 2019 | 726 | 0.180 |
Why?
|
Hepacivirus | 1 | 2007 | 1342 | 0.180 |
Why?
|
Cresols | 1 | 2020 | 26 | 0.170 |
Why?
|
Promoter Regions, Genetic | 4 | 2014 | 5801 | 0.170 |
Why?
|
Vascular System Injuries | 1 | 2023 | 248 | 0.170 |
Why?
|
Coronary Restenosis | 1 | 2023 | 396 | 0.170 |
Why?
|
DNA, Bacterial | 1 | 2005 | 1479 | 0.170 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2006 | 2524 | 0.170 |
Why?
|
Nepovirus | 2 | 1996 | 2 | 0.170 |
Why?
|
Rural Population | 4 | 2022 | 2318 | 0.170 |
Why?
|
Europe | 10 | 2017 | 3439 | 0.160 |
Why?
|
Asthma | 2 | 2016 | 6280 | 0.160 |
Why?
|
Population Density | 3 | 2019 | 193 | 0.160 |
Why?
|
Cultural Characteristics | 1 | 2020 | 250 | 0.160 |
Why?
|
Genetic Linkage | 5 | 2017 | 2342 | 0.160 |
Why?
|
Smoking | 3 | 2017 | 9111 | 0.160 |
Why?
|
Tumor Virus Infections | 1 | 2002 | 438 | 0.160 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5375 | 0.160 |
Why?
|
Blood Glucose | 3 | 2020 | 6430 | 0.160 |
Why?
|
Urinalysis | 1 | 2020 | 369 | 0.150 |
Why?
|
Bible | 1 | 2018 | 5 | 0.150 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2012 | 276 | 0.150 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2002 | 391 | 0.150 |
Why?
|
Italy | 2 | 2018 | 854 | 0.150 |
Why?
|
Age of Onset | 5 | 2013 | 3345 | 0.150 |
Why?
|
Asia | 6 | 2017 | 627 | 0.140 |
Why?
|
Influenza in Birds | 1 | 2018 | 76 | 0.140 |
Why?
|
Hepatitis C | 1 | 2007 | 1593 | 0.140 |
Why?
|
Leptin | 2 | 2002 | 1597 | 0.140 |
Why?
|
Exons | 3 | 2008 | 2392 | 0.140 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2018 | 115 | 0.140 |
Why?
|
Chromosomes, Human, X | 2 | 2016 | 320 | 0.140 |
Why?
|
Adolescent | 15 | 2019 | 89184 | 0.140 |
Why?
|
Prenatal Diagnosis | 1 | 2004 | 1274 | 0.140 |
Why?
|
Recombination, Genetic | 2 | 2011 | 1526 | 0.140 |
Why?
|
Medical Records | 1 | 2002 | 1412 | 0.140 |
Why?
|
Tunisia | 1 | 2016 | 36 | 0.140 |
Why?
|
Influenza, Human | 2 | 2018 | 1539 | 0.130 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11516 | 0.130 |
Why?
|
Osteoporosis | 2 | 2022 | 1606 | 0.130 |
Why?
|
Cyprus | 1 | 2016 | 96 | 0.130 |
Why?
|
Periodontitis | 1 | 2021 | 577 | 0.130 |
Why?
|
Thromboembolism | 1 | 2003 | 1004 | 0.130 |
Why?
|
Factor V | 2 | 2010 | 168 | 0.130 |
Why?
|
HIV-1 | 1 | 2014 | 6963 | 0.130 |
Why?
|
Tooth | 1 | 2018 | 210 | 0.130 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2015 | 68 | 0.130 |
Why?
|
Viral Core Proteins | 1 | 1996 | 158 | 0.130 |
Why?
|
Sentinel Surveillance | 1 | 2018 | 292 | 0.130 |
Why?
|
HLA-DQ Antigens | 3 | 2009 | 190 | 0.130 |
Why?
|
Chickens | 1 | 2018 | 845 | 0.130 |
Why?
|
Africa South of the Sahara | 3 | 2019 | 751 | 0.130 |
Why?
|
Lipoproteins, LDL | 1 | 2019 | 643 | 0.130 |
Why?
|
Bone Density | 2 | 2022 | 3559 | 0.130 |
Why?
|
Papillomaviridae | 1 | 2002 | 1140 | 0.130 |
Why?
|
Dyslipidemias | 1 | 2023 | 873 | 0.120 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2021 | 1122 | 0.120 |
Why?
|
Prevalence | 7 | 2014 | 15872 | 0.120 |
Why?
|
tRNA Methyltransferases | 1 | 2014 | 50 | 0.120 |
Why?
|
Pancreas | 1 | 2021 | 1702 | 0.120 |
Why?
|
Arabs | 1 | 2017 | 189 | 0.120 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 2005 | 767 | 0.120 |
Why?
|
Cholesterol, LDL | 3 | 2019 | 2398 | 0.120 |
Why?
|
Lipoproteins, HDL | 1 | 2019 | 682 | 0.110 |
Why?
|
Reverse Transcription | 1 | 2014 | 48 | 0.110 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 2 | 2007 | 167 | 0.110 |
Why?
|
HIV Protease | 1 | 2014 | 98 | 0.110 |
Why?
|
Amyloidosis, Familial | 1 | 2013 | 16 | 0.110 |
Why?
|
Culture | 1 | 2018 | 623 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5891 | 0.110 |
Why?
|
Bioartificial Organs | 1 | 2013 | 47 | 0.110 |
Why?
|
Alstrom Syndrome | 1 | 2013 | 11 | 0.110 |
Why?
|
Cultural Evolution | 1 | 2013 | 9 | 0.110 |
Why?
|
Cluster Analysis | 4 | 2016 | 2728 | 0.110 |
Why?
|
HIV Reverse Transcriptase | 1 | 2014 | 214 | 0.110 |
Why?
|
Hyperglycemia | 1 | 2021 | 1389 | 0.100 |
Why?
|
Base Sequence | 7 | 2017 | 12422 | 0.100 |
Why?
|
Sequence Analysis, DNA | 4 | 2014 | 4775 | 0.100 |
Why?
|
Corneal Dystrophies, Hereditary | 1 | 2013 | 62 | 0.100 |
Why?
|
Regression Analysis | 2 | 2020 | 6350 | 0.100 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3438 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 362 | 0.100 |
Why?
|
Heart Valve Prosthesis | 1 | 2020 | 1468 | 0.100 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2201 | 0.100 |
Why?
|
Membrane Proteins | 1 | 2008 | 7880 | 0.090 |
Why?
|
Hyperhomocysteinemia | 1 | 2012 | 118 | 0.090 |
Why?
|
Young Adult | 10 | 2021 | 60049 | 0.090 |
Why?
|
Caffeine | 1 | 2015 | 702 | 0.090 |
Why?
|
Genetic Markers | 2 | 2008 | 2604 | 0.090 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2010 | 34 | 0.090 |
Why?
|
Interferon-alpha | 2 | 2007 | 910 | 0.090 |
Why?
|
Biological Evolution | 2 | 2015 | 1078 | 0.090 |
Why?
|
Fertility Agents, Female | 1 | 2010 | 101 | 0.090 |
Why?
|
Respiratory Tract Infections | 1 | 2018 | 1014 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2917 | 0.090 |
Why?
|
Inflammation | 2 | 2023 | 10863 | 0.090 |
Why?
|
Milk | 2 | 2003 | 443 | 0.080 |
Why?
|
Papillomavirus Infections | 1 | 2002 | 1640 | 0.080 |
Why?
|
Population Groups | 1 | 2010 | 208 | 0.080 |
Why?
|
Cost of Illness | 2 | 2018 | 1959 | 0.080 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15939 | 0.080 |
Why?
|
Infection Control | 1 | 2016 | 985 | 0.080 |
Why?
|
Chromosome Mapping | 2 | 2015 | 4622 | 0.080 |
Why?
|
Tandem Repeat Sequences | 2 | 2009 | 183 | 0.080 |
Why?
|
Mediterranean Sea | 1 | 2008 | 13 | 0.080 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2010 | 279 | 0.080 |
Why?
|
Stroke | 2 | 2022 | 9742 | 0.080 |
Why?
|
Prosthesis Implantation | 1 | 2013 | 594 | 0.080 |
Why?
|
Wolfram Syndrome | 1 | 2008 | 14 | 0.080 |
Why?
|
Child | 11 | 2018 | 80891 | 0.080 |
Why?
|
Homocysteine | 1 | 2012 | 637 | 0.080 |
Why?
|
Body Height | 1 | 2015 | 1568 | 0.080 |
Why?
|
Child, Preschool | 8 | 2018 | 42650 | 0.080 |
Why?
|
Protein Isoforms | 1 | 2013 | 1703 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2018 | 1762 | 0.080 |
Why?
|
Streptococcus agalactiae | 1 | 2010 | 338 | 0.080 |
Why?
|
Cohort Studies | 6 | 2022 | 41795 | 0.080 |
Why?
|
Diet | 1 | 2006 | 8090 | 0.070 |
Why?
|
Echocardiography | 1 | 2020 | 5044 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1407 | 0.070 |
Why?
|
Drug Costs | 1 | 2016 | 1196 | 0.070 |
Why?
|
Behcet Syndrome | 1 | 2008 | 86 | 0.070 |
Why?
|
Brucellosis | 1 | 2007 | 21 | 0.070 |
Why?
|
Histocytological Preparation Techniques | 1 | 2007 | 33 | 0.070 |
Why?
|
Cross-Sectional Studies | 7 | 2020 | 26375 | 0.070 |
Why?
|
HIV Infections | 1 | 2014 | 17575 | 0.070 |
Why?
|
Biotinidase Deficiency | 1 | 2006 | 3 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 1996 | 1883 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12092 | 0.070 |
Why?
|
Isotretinoin | 1 | 2008 | 134 | 0.070 |
Why?
|
HTLV-I Infections | 1 | 2007 | 104 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2020 | 4785 | 0.070 |
Why?
|
Glomerulonephritis, IGA | 1 | 2006 | 61 | 0.070 |
Why?
|
Microbiological Techniques | 1 | 2007 | 97 | 0.070 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2007 | 143 | 0.070 |
Why?
|
Heterozygote | 3 | 2016 | 2791 | 0.070 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2010 | 503 | 0.060 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2006 | 229 | 0.060 |
Why?
|
Antigens, CD | 2 | 2008 | 4031 | 0.060 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2006 | 192 | 0.060 |
Why?
|
Language | 2 | 2015 | 1558 | 0.060 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2006 | 247 | 0.060 |
Why?
|
Logistic Models | 4 | 2016 | 13323 | 0.060 |
Why?
|
Albinism, Oculocutaneous | 1 | 2005 | 19 | 0.060 |
Why?
|
Streptococcal Infections | 1 | 2010 | 619 | 0.060 |
Why?
|
Monophenol Monooxygenase | 1 | 2005 | 71 | 0.060 |
Why?
|
Proviruses | 1 | 2007 | 320 | 0.060 |
Why?
|
Cotinine | 1 | 2005 | 206 | 0.060 |
Why?
|
Risk Assessment | 4 | 2016 | 24318 | 0.060 |
Why?
|
Zidovudine | 1 | 2007 | 625 | 0.060 |
Why?
|
Algorithms | 3 | 2019 | 14154 | 0.060 |
Why?
|
Quantitative Trait Loci | 1 | 2012 | 2127 | 0.060 |
Why?
|
Insurance Coverage | 1 | 2016 | 1946 | 0.060 |
Why?
|
Dermatologic Agents | 1 | 2008 | 312 | 0.060 |
Why?
|
Infant | 6 | 2021 | 36510 | 0.060 |
Why?
|
NF-kappa B | 2 | 2010 | 2489 | 0.060 |
Why?
|
Iran | 3 | 2015 | 762 | 0.060 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2005 | 1056 | 0.060 |
Why?
|
Ethiopia | 2 | 2016 | 482 | 0.060 |
Why?
|
Oligonucleotide Probes | 1 | 2004 | 417 | 0.060 |
Why?
|
Depression | 1 | 2023 | 8241 | 0.050 |
Why?
|
Hemoglobin A2 | 1 | 2003 | 6 | 0.050 |
Why?
|
Blood Protein Electrophoresis | 1 | 2003 | 65 | 0.050 |
Why?
|
Family Health | 2 | 2010 | 1255 | 0.050 |
Why?
|
Health Expenditures | 1 | 2016 | 2395 | 0.050 |
Why?
|
Hemoglobin A | 1 | 2003 | 84 | 0.050 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 179 | 0.050 |
Why?
|
Birth Order | 1 | 2003 | 95 | 0.050 |
Why?
|
Spasms, Infantile | 1 | 2006 | 301 | 0.050 |
Why?
|
Health Personnel | 1 | 2016 | 3380 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4588 | 0.050 |
Why?
|
alpha-Thalassemia | 1 | 2003 | 53 | 0.050 |
Why?
|
Health | 1 | 2005 | 399 | 0.050 |
Why?
|
Homozygote | 2 | 2004 | 1779 | 0.050 |
Why?
|
Arsenicals | 1 | 2003 | 117 | 0.050 |
Why?
|
Coronary Disease | 1 | 2017 | 5924 | 0.050 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2003 | 97 | 0.050 |
Why?
|
Syndrome | 1 | 2008 | 3275 | 0.050 |
Why?
|
Receptors, CCR5 | 1 | 2004 | 491 | 0.050 |
Why?
|
Molecular Sequence Data | 4 | 2015 | 17626 | 0.050 |
Why?
|
Streptozocin | 1 | 2021 | 190 | 0.050 |
Why?
|
Anthropometry | 1 | 2006 | 1343 | 0.050 |
Why?
|
Point Mutation | 1 | 2006 | 1594 | 0.050 |
Why?
|
Drinking | 1 | 2002 | 197 | 0.050 |
Why?
|
Oxides | 1 | 2003 | 403 | 0.050 |
Why?
|
Aspartate Aminotransferases | 1 | 2022 | 414 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2019 | 59686 | 0.050 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2005 | 1050 | 0.050 |
Why?
|
Species Specificity | 1 | 2005 | 2417 | 0.040 |
Why?
|
Antiviral Agents | 2 | 2018 | 3064 | 0.040 |
Why?
|
Models, Genetic | 3 | 2017 | 3442 | 0.040 |
Why?
|
Y Chromosome | 1 | 2001 | 205 | 0.040 |
Why?
|
Graft Rejection | 1 | 2013 | 4505 | 0.040 |
Why?
|
Organogenesis | 1 | 2021 | 214 | 0.040 |
Why?
|
Mutagenesis, Insertional | 1 | 2003 | 662 | 0.040 |
Why?
|
Absorptiometry, Photon | 1 | 2006 | 1752 | 0.040 |
Why?
|
Gallbladder | 1 | 2021 | 308 | 0.040 |
Why?
|
Comorbidity | 1 | 2014 | 10588 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2005 | 15649 | 0.040 |
Why?
|
Autoantibodies | 1 | 2008 | 2126 | 0.040 |
Why?
|
Multigene Family | 1 | 2003 | 1082 | 0.040 |
Why?
|
Fossils | 1 | 2019 | 76 | 0.040 |
Why?
|
Obesity | 2 | 2020 | 13084 | 0.040 |
Why?
|
Pancreatic Diseases | 1 | 2021 | 353 | 0.040 |
Why?
|
Animals | 9 | 2023 | 169337 | 0.040 |
Why?
|
Fasting | 1 | 2005 | 1610 | 0.040 |
Why?
|
Fabaceae | 2 | 1996 | 104 | 0.040 |
Why?
|
Vaginal Smears | 1 | 2002 | 505 | 0.040 |
Why?
|
Nutrition Surveys | 1 | 2006 | 1736 | 0.040 |
Why?
|
Plants, Medicinal | 2 | 1996 | 167 | 0.040 |
Why?
|
Body Mass Index | 3 | 2021 | 13052 | 0.040 |
Why?
|
Premature Birth | 1 | 2010 | 1814 | 0.040 |
Why?
|
Proteins | 1 | 2013 | 6006 | 0.040 |
Why?
|
Sex Distribution | 1 | 2003 | 2281 | 0.040 |
Why?
|
Hospitalization | 1 | 2018 | 10844 | 0.040 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2010 | 2185 | 0.040 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2018 | 85 | 0.040 |
Why?
|
Oseltamivir | 1 | 2018 | 75 | 0.040 |
Why?
|
Vitamin B 12 | 1 | 2020 | 527 | 0.040 |
Why?
|
Triglycerides | 2 | 2015 | 2465 | 0.040 |
Why?
|
Fetal Growth Retardation | 1 | 2021 | 591 | 0.040 |
Why?
|
Chad | 1 | 2016 | 9 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2017 | 20224 | 0.040 |
Why?
|
Seasons | 1 | 2003 | 1526 | 0.030 |
Why?
|
Morbidity | 1 | 2022 | 1758 | 0.030 |
Why?
|
Postmenopause | 1 | 2006 | 2518 | 0.030 |
Why?
|
Creatinine | 1 | 2022 | 1915 | 0.030 |
Why?
|
HLA Antigens | 1 | 2002 | 1337 | 0.030 |
Why?
|
Congenital Abnormalities | 1 | 2021 | 708 | 0.030 |
Why?
|
Pilot Projects | 2 | 2018 | 8731 | 0.030 |
Why?
|
Probability | 1 | 2002 | 2482 | 0.030 |
Why?
|
Ribonuclease H | 1 | 1996 | 52 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2003 | 1309 | 0.030 |
Why?
|
Armenia | 1 | 2015 | 16 | 0.030 |
Why?
|
Databases, Genetic | 2 | 2014 | 1748 | 0.030 |
Why?
|
Neoplasms | 2 | 2016 | 22385 | 0.030 |
Why?
|
Age Distribution | 1 | 2002 | 2877 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2007 | 3520 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2004 | 4120 | 0.030 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2015 | 89 | 0.030 |
Why?
|
Sex Factors | 2 | 2015 | 10654 | 0.030 |
Why?
|
Aryldialkylphosphatase | 1 | 2015 | 64 | 0.030 |
Why?
|
DNA, Viral | 1 | 2002 | 2205 | 0.030 |
Why?
|
Nasopharynx | 1 | 2018 | 420 | 0.030 |
Why?
|
Breast Feeding | 1 | 2003 | 1364 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1996 | 706 | 0.030 |
Why?
|
Pluripotent Stem Cells | 1 | 2021 | 808 | 0.030 |
Why?
|
Dyspnea | 1 | 2022 | 1351 | 0.030 |
Why?
|
Rats | 2 | 2021 | 23835 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2022 | 81801 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2004 | 2708 | 0.030 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2018 | 450 | 0.030 |
Why?
|
Mass Screening | 1 | 2010 | 5451 | 0.030 |
Why?
|
Diabetic Nephropathies | 1 | 2001 | 975 | 0.030 |
Why?
|
Leukotrienes | 1 | 2015 | 232 | 0.030 |
Why?
|
Diabetes Insipidus, Neurogenic | 1 | 2013 | 20 | 0.030 |
Why?
|
Ketosis | 1 | 2013 | 46 | 0.030 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2016 | 423 | 0.030 |
Why?
|
Agriculture | 1 | 2014 | 187 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2021 | 1421 | 0.030 |
Why?
|
Primary Prevention | 1 | 2020 | 1187 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1890 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13697 | 0.030 |
Why?
|
Workflow | 1 | 2017 | 859 | 0.030 |
Why?
|
Lumbar Vertebrae | 1 | 2022 | 1885 | 0.030 |
Why?
|
Incidence | 3 | 2010 | 21544 | 0.030 |
Why?
|
Morocco | 1 | 2012 | 36 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2017 | 1364 | 0.020 |
Why?
|
Afghanistan | 1 | 2012 | 77 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 3722 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2429 | 0.020 |
Why?
|
Asia, Central | 1 | 2011 | 13 | 0.020 |
Why?
|
Piperazines | 1 | 2003 | 2552 | 0.020 |
Why?
|
Vitamins | 1 | 2020 | 1637 | 0.020 |
Why?
|
Systems Biology | 1 | 2016 | 479 | 0.020 |
Why?
|
Software | 1 | 2006 | 4453 | 0.020 |
Why?
|
Asia, Southeastern | 1 | 2011 | 115 | 0.020 |
Why?
|
Health Surveys | 1 | 2002 | 4056 | 0.020 |
Why?
|
Markov Chains | 1 | 2015 | 977 | 0.020 |
Why?
|
Pregnancy | 3 | 2010 | 30200 | 0.020 |
Why?
|
Genome | 1 | 2019 | 1747 | 0.020 |
Why?
|
Lens, Crystalline | 1 | 2013 | 387 | 0.020 |
Why?
|
Organic Anion Transporters | 1 | 2012 | 101 | 0.020 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2010 | 1360 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2445 | 0.020 |
Why?
|
Flucytosine | 1 | 2010 | 33 | 0.020 |
Why?
|
Renin-Angiotensin System | 1 | 2016 | 739 | 0.020 |
Why?
|
Coffee | 1 | 2015 | 598 | 0.020 |
Why?
|
Internationality | 1 | 2016 | 1008 | 0.020 |
Why?
|
Linguistics | 1 | 2011 | 110 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1996 | 3055 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2021 | 26411 | 0.020 |
Why?
|
Russia | 1 | 2011 | 386 | 0.020 |
Why?
|
DNA | 1 | 2004 | 7211 | 0.020 |
Why?
|
Pyrimidines | 1 | 2003 | 3048 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2015 | 773 | 0.020 |
Why?
|
Lipids | 1 | 2021 | 3344 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2002 | 3334 | 0.020 |
Why?
|
Corneal Transplantation | 1 | 2013 | 315 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2002 | 3108 | 0.020 |
Why?
|
Protons | 1 | 2015 | 1112 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39407 | 0.020 |
Why?
|
Serotyping | 1 | 2010 | 332 | 0.020 |
Why?
|
Data Mining | 1 | 2014 | 560 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2017 | 2353 | 0.020 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2010 | 139 | 0.020 |
Why?
|
Diuretics | 1 | 2012 | 612 | 0.020 |
Why?
|
Homeostasis | 1 | 2020 | 3349 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 15455 | 0.020 |
Why?
|
Obstetric Labor, Premature | 1 | 2010 | 273 | 0.020 |
Why?
|
Insulin | 1 | 2002 | 6607 | 0.020 |
Why?
|
Lentivirus | 1 | 2010 | 519 | 0.020 |
Why?
|
Pain | 1 | 2003 | 5103 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7599 | 0.020 |
Why?
|
Genomics | 2 | 2015 | 5916 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 1614 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7242 | 0.020 |
Why?
|
Virus Replication | 1 | 1995 | 2458 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54920 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2017 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9510 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 2013 | 1279 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2008 | 515 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2862 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2017 | 3125 | 0.020 |
Why?
|
Time Factors | 3 | 2017 | 40272 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 1999 | 0.020 |
Why?
|
Hematuria | 1 | 2006 | 233 | 0.020 |
Why?
|
Neonatal Screening | 1 | 2010 | 618 | 0.020 |
Why?
|
RNA | 1 | 1995 | 2726 | 0.020 |
Why?
|
Siblings | 1 | 2009 | 829 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2010 | 3587 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2015 | 3781 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 1996 | 13423 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3632 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10478 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2012 | 1753 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2021 | 11668 | 0.010 |
Why?
|
Diabetic Retinopathy | 1 | 2013 | 1299 | 0.010 |
Why?
|
Visual Acuity | 1 | 2013 | 2714 | 0.010 |
Why?
|
HIV Seronegativity | 1 | 2004 | 210 | 0.010 |
Why?
|
Gene Products, tax | 1 | 2003 | 51 | 0.010 |
Why?
|
Computational Biology | 1 | 2015 | 3543 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2010 | 21162 | 0.010 |
Why?
|
Internet | 1 | 2015 | 3107 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3666 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8753 | 0.010 |
Why?
|
Frameshift Mutation | 1 | 2004 | 393 | 0.010 |
Why?
|
Blood Donors | 1 | 2004 | 344 | 0.010 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 183 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 11854 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3458 | 0.010 |
Why?
|
Gestational Age | 1 | 2010 | 3615 | 0.010 |
Why?
|
Trisomy | 1 | 2003 | 260 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19022 | 0.010 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2003 | 453 | 0.010 |
Why?
|
Karyotyping | 1 | 2003 | 1173 | 0.010 |
Why?
|
Infant, Premature | 1 | 2010 | 2124 | 0.010 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2003 | 430 | 0.010 |
Why?
|
Signal Transduction | 1 | 2023 | 23631 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2003 | 542 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 2004 | 1158 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2013 | 3981 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2010 | 2961 | 0.010 |
Why?
|
Mice | 2 | 2020 | 82017 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2003 | 1605 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15597 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 2825 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3707 | 0.010 |
Why?
|
Viral Load | 1 | 2007 | 3398 | 0.010 |
Why?
|
Benzamides | 1 | 2003 | 1380 | 0.010 |
Why?
|
Albuminuria | 1 | 2001 | 658 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2007 | 6318 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2010 | 7861 | 0.010 |
Why?
|
Gene Deletion | 1 | 2004 | 2673 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 6241 | 0.010 |
Why?
|
RNA, Satellite | 1 | 1995 | 16 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6132 | 0.010 |
Why?
|
Biopsy | 1 | 2006 | 6808 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 4859 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2006 | 2491 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2010 | 17135 | 0.010 |
Why?
|
Population Surveillance | 1 | 2004 | 2598 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2003 | 2433 | 0.010 |
Why?
|
Virion | 1 | 1995 | 430 | 0.010 |
Why?
|
Cell Survival | 1 | 2003 | 5792 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14737 | 0.010 |
Why?
|
Nucleic Acid Conformation | 1 | 1995 | 900 | 0.010 |
Why?
|
Prognosis | 1 | 2006 | 30022 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2007 | 65379 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2006 | 36849 | 0.000 |
Why?
|